AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
This research involving human participants complies with all relevant ethical regulations, including obtaining informed consent from all participants through the recruitment sites. Ethical review and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results